Market Tracker

05/22 5:16pm ET

Transition Therapeutics Inc (NASDAQ:TTHI)

6.91
Delayed Data
As of May 22
 -0.01 / -0.14%
Today’s Change
4.95
Today|||52-Week Range
8.50
+1.07%
Year-to-Date
No recent news for Transition Therapeutics Inc.

Today’s Trading

Previous close6.92
Today’s open6.82
Day’s range6.80 - 6.98
Volume14,306
Average volume (3 months)29,721
Market cap$268.5M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-74,855.56%
Earnings growth (this year)-60.76%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book4.40

Competitors

 Today’s
change
Today’s
% change
TROVTrovagene Inc+0.64+6.22%
QTNTQuotient Ltd-0.26-1.73%
VCYTVeracyte Inc-0.15-1.38%
OXFDOxford Immunotec Glo...+0.11+0.82%
Data as of 3:59pm ET, 05/22/2015

Financials

Last reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts